Trilogy Writing and Consulting Logo

The Patient’s Voice Through Social Media

December 15, 2015 | London, UK

Trilogy hosted a discussion on “Are we ready for the patient’s voice through social media in the benefit-risk assessment of drugs?” amongst a small group of peer experts and together with our speakers:

  • Phil Tregunno (Signal Management and Quality Standards Unit Manager at MHRA)
  • Sue Rees (EU QPPV, Executive Director at Amgen)